-
What’s behind the low vaccine rate among teens?
ANN ARBOR, Mich. — Parents may be up to speed on what vaccines their children need for kindergarten, but may be less sure during high school years, a new national poll suggests.
More than a third of parents of teens didn't know when their child's next vaccine was due and half of parents incorrectly assumed that their doctor would initiate an appointment when the time came, according to a report from the C.S. Mott Children's Hospital National Poll on Children's Health at the University of Michigan released on Monday.
-
FDA grants full approval to Amgen’s Blincyto
SILVER SPRING, Md. — Patients with a certain type of acute lymphoblastic leukemia have a new treatment option. The Food and Drug Administration has granted Amgen’s Blincyto (blinatumomab) full approval for the treatment of Philadelphia Chromosome-positive relaped or refractory B-cell precursor ALL.